Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD) and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance cholinergic and dopaminergic neurotransmission in AD and PD, respectively, and few studies have examined noradrenergic dysfuncti...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2018-05-01
|
| Schriftenreihe: | Frontiers in Aging Neuroscience |
| Schlagworte: | |
| Online-Zugang: | http://journal.frontiersin.org/article/10.3389/fnagi.2018.00127/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
